home All News open_in_new Full Article
Celltrion’s Autoimmune Disease Treatment Aptozma Receives Product Approval in Japan
today 2 w. ago attach_file Other
attach_file
Other
attach_file
Other
attach_file
Other
attach_file
Other
attach_file
Other
attach_file
Other
attach_file
Other
attach_file
Other
attach_file
Other
attach_file
Other
attach_file
Other
ID: 1334706322